Listen "Rapid adoption expected of Boston Scientific's Farapulse, Medtronic ICDs have life-saving potential"
Episode Synopsis
SmileDirectClub and Align Technology are in a legal proceeding from a previous partnership. Fast Five hosts Sean Whooley and Danielle Kirsh discuss SDC's plans to appeal a court order that said it has to pay Align Technology $63 million. In today's episode, find out more about the proceeding and the SmileDirectClub's appeal.
GE Healthcare has unveiled its latest wireless, handheld ultrasound device. Whooley explains what the device does, how accompanying digital tools help clinicians and what executives think about this unveiling.
Diabetes news and continuous glucose monitors continue to innovate. This week, Insulet launched its Omnipod 5 in Germany and announced when it expects a full European launch. Whooley outlines the regulatory pathway Omnipod 5 took to get to the Germany launch and how patients and executives feel about its entry into Europe.
This week, we have study data from the European Society of Cardiology (ESC) in Amsterdam. Medtronic posted study results that demonstrated ICDs could prevent sudden cardiac death. Hear some of the data points from the study.
Boston Scientific also posted results from ESC. Its Farapulse pulsed-field ablation device had positive results – and analysts now expect FDA approval and rapid adoption on the U.S. market. Listen to today's episode for more details.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
GE Healthcare has unveiled its latest wireless, handheld ultrasound device. Whooley explains what the device does, how accompanying digital tools help clinicians and what executives think about this unveiling.
Diabetes news and continuous glucose monitors continue to innovate. This week, Insulet launched its Omnipod 5 in Germany and announced when it expects a full European launch. Whooley outlines the regulatory pathway Omnipod 5 took to get to the Germany launch and how patients and executives feel about its entry into Europe.
This week, we have study data from the European Society of Cardiology (ESC) in Amsterdam. Medtronic posted study results that demonstrated ICDs could prevent sudden cardiac death. Hear some of the data points from the study.
Boston Scientific also posted results from ESC. Its Farapulse pulsed-field ablation device had positive results – and analysts now expect FDA approval and rapid adoption on the U.S. market. Listen to today's episode for more details.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.